TGFB1 and COVID-19: Consistent with this hypothesis, SARS-CoV-2 Tregs are reduced in hospitalized COVID-19 patients (35) and TGF-β+CD28- naïve CD8+ T cells are higher in patients with mild than severe COVID-19 (36).